179 related articles for article (PubMed ID: 36352998)
1. Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study.
Yousuf SD; Ganie MA; Mudassar S; Shafi H; Ibrahim S; Jeelani H; Rashid G; Zargar MA; Rashid F
J Family Med Prim Care; 2022 Aug; 11(8):4743-4752. PubMed ID: 36352998
[TBL] [Abstract][Full Text] [Related]
2. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
Lin S; Huiya Z; Bo L; Wei W; Yongmei G
Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.
Diamanti-Kandarakis E; Palioniko G; Alexandraki K; Bergiele A; Koutsouba T; Bartzis M
Eur J Endocrinol; 2004 Jun; 150(6):793-8. PubMed ID: 15191349
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
Sun L; Lv H; Wei W; Zhang D; Guan Y
J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
Lee YH; Song GG
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
[TBL] [Abstract][Full Text] [Related]
6. Family-based analysis of -675 4G/5G polymorphism in the PAI-1 gene of polycystic ovary syndrome in Chinese population.
Song X; Ge L; Wang D; Li L; Ma D; Li X; Song X
J Obstet Gynaecol; 2022 Oct; 42(7):3304-3308. PubMed ID: 36065507
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women.
Mary MJ; Saravanan L; Deecaraman M; Vijayalakshmi M; Umashankar V; Sailaja J
Bioinformation; 2017; 13(5):149-153. PubMed ID: 28690381
[TBL] [Abstract][Full Text] [Related]
8. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
[TBL] [Abstract][Full Text] [Related]
9. Association between the -844 G>A, HindIII C>G, and 4G/5G
Valdés-Alvarado E; Huerta M; Trujillo X; Valle Y; Padilla Gutiérrez JR; Mireles-Ramírez MA; Macías-Islas MA; Luz Margarita BR; Muñoz-Valle JF
Dis Markers; 2019; 2019():9626289. PubMed ID: 31687051
[TBL] [Abstract][Full Text] [Related]
10. [Reproductive problems in women with PCOS, the impact of PAI-1 carriers of 4G PAI-1 polymorphism and BMI].
Komsa-Penkova R; Golemanov G; Georgieva G; Popovski K; Slavov N; Ivanov P; Kovacheva K; Atanasova M; Blajev A
Akush Ginekol (Sofiia); 2014; 53(6):15-21. PubMed ID: 25672133
[TBL] [Abstract][Full Text] [Related]
11. [Reproductive problems in women with PCOS, the impact of PAL-1 CARRIERS OF 4G PAI -1 polymorphism and BMI].
Komsa-Penkova R; Golemanov G; Georgieva G; Slavov N; Popovski K; Ivanov P; Kovacheva K; Atanasova M; Blajev A
Akush Ginekol (Sofiia); 2014; 53(5):3-9. PubMed ID: 25558663
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.
Bagos PG
Mol Hum Reprod; 2009 Jan; 15(1):19-26. PubMed ID: 19066200
[TBL] [Abstract][Full Text] [Related]
13. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
[TBL] [Abstract][Full Text] [Related]
14. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
[TBL] [Abstract][Full Text] [Related]
15. 4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study.
Madách K; Aladzsity I; Szilágyi A; Fust G; Gál J; Pénzes I; Prohászka Z
Crit Care; 2010; 14(2):R79. PubMed ID: 20429897
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome.
Idali F; Zareii S; Mohammad-Zadeh A; Reihany-Sabet F; Akbarzadeh-Pasha Z; Khorram-Khorshid HR; Zarnani AH; Jeddi-Tehrani M
Am J Reprod Immunol; 2012 Nov; 68(5):400-7. PubMed ID: 22882325
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women.
Yousuf SD; Ganie MA; Urwat U; Andrabi SM; Zargar MA; Dar MA; Manzoor-Ul-Rehman M; Mudassar S; Rashid F
BMC Womens Health; 2023 Feb; 23(1):68. PubMed ID: 36793022
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis.
Liu Y; Sun MG; Jiang R; Ding R; Che Z; Chen YY; Yao CJ; Zhu XX; Cao JY
J Assist Reprod Genet; 2014 Mar; 31(3):363-70. PubMed ID: 24435452
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome.
Kilicci C; Bayram B; Ozkurt M; Onlu H; Erkasap N; Mutlu F
Genet Test Mol Biomarkers; 2011; 15(7-8):565-7. PubMed ID: 21413876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
